Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet R Vos

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Clinical Genetics|April 28, 2025
Deep Phenotyping of Pathology-Confirmed Benign Lesions in PTEN Hamartoma Tumor Syndrome PatientsAne J Schei-Andersen, Janneke H M Schuurs-Hoeijmakers, Rachel van der Post, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation CarriersJanet R Vos, Li Hsu, Richard M Brohet, et al.
European Journal of Medical Genetics|May 31, 2022
Catch them if you are aware: PTEN postzygotic mosaicism in clinically suspicious patients with PTEN Hamartoma Tumour Syndrome and literature reviewLinda A J Hendricks, Janneke Schuurs-Hoeijmakers, Isabel Spier, et al.
International Dental Journal|May 2, 2024
Exploring the Prevalence of Oral Features for Early Detection of PTEN Hamartoma Tumour SyndromeAne J Schei-Andersen, Bart van Oirschot, Meggie M C M Drissen, et al.
Familial Cancer|March 18, 2025
Non-serous ovarian cancer in PTEN Hamartoma Tumor Syndrome: additional evidence for increased riskAne J Schei-Andersen, Vera M Witjes, Janet R Vos, et al.
International Journal of Cancer|June 11, 2024
Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center studyAne J Schei-Andersen, Linda A J Hendricks, Rachel S van der Post, et al.
International Journal of Cancer|June 9, 2020
Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndromeJanet R Vos, Ingrid E Fakkert, Liesbeth Spruijt, et al.
Journal of the National Cancer Institute|April 5, 2023
Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndromeLisa Elze, Rachel S van der Post, Janet R Vos, et al.
Gynecologic Oncology|October 27, 2021
Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysisVera M Witjes, Majke H D van Bommel, Marjolijn J L Ligtenberg, et al.
Gynecologic Oncology|May 14, 2023
The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?Vera M Witjes, Marjolijn J L Ligtenberg, Janet R Vos, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Clinical Genetics|April 28, 2025
Deep Phenotyping of Pathology-Confirmed Benign Lesions in PTEN Hamartoma Tumor Syndrome PatientsAne J Schei-Andersen, Janneke H M Schuurs-Hoeijmakers, Rachel van der Post, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation CarriersJanet R Vos, Li Hsu, Richard M Brohet, et al.
European Journal of Medical Genetics|May 31, 2022
Catch them if you are aware: PTEN postzygotic mosaicism in clinically suspicious patients with PTEN Hamartoma Tumour Syndrome and literature reviewLinda A J Hendricks, Janneke Schuurs-Hoeijmakers, Isabel Spier, et al.
International Dental Journal|May 2, 2024
Exploring the Prevalence of Oral Features for Early Detection of PTEN Hamartoma Tumour SyndromeAne J Schei-Andersen, Bart van Oirschot, Meggie M C M Drissen, et al.
Familial Cancer|March 18, 2025
Non-serous ovarian cancer in PTEN Hamartoma Tumor Syndrome: additional evidence for increased riskAne J Schei-Andersen, Vera M Witjes, Janet R Vos, et al.
International Journal of Cancer|June 11, 2024
Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center studyAne J Schei-Andersen, Linda A J Hendricks, Rachel S van der Post, et al.
International Journal of Cancer|June 9, 2020
Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndromeJanet R Vos, Ingrid E Fakkert, Liesbeth Spruijt, et al.
Journal of the National Cancer Institute|April 5, 2023
Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndromeLisa Elze, Rachel S van der Post, Janet R Vos, et al.
Gynecologic Oncology|October 27, 2021
Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysisVera M Witjes, Majke H D van Bommel, Marjolijn J L Ligtenberg, et al.
Gynecologic Oncology|May 14, 2023
The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?Vera M Witjes, Marjolijn J L Ligtenberg, Janet R Vos, et al.
Pageof 4